Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy
Open accessThe DOI matches its Crossref record; 227 of the 228 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Lipopolysaccharide (LPS), also referred to as endotoxin, is the major component of Gram-negative bacteria’s outer cell wall. It is one of the main types of pathogen-associated molecular patterns (PAMPs) that are known to elicit severe immune reactions in the event of a pathogen trespassing the epithelial barrier and reaching the bloodstream. Associated symptoms include fever and septic shock, which in severe cases, might even lead to death. Thus, the detection of LPS in medical devices and injectable pharmaceuticals is of utmost importance. However, the term LPS does not describe one single molecule but a diverse class of molecules sharing one common feature: their characteristic chemical structure. Each bacterial species has its own pool of LPS molecules varying in their chemical composition and enabling the aggregation into different supramolecular structures upon release from the bacterial cell wall. As this heterogeneity has consequences for bioassays, we aim to examine the great variability of LPS molecules and their potential to form various supramolecular structures. Furthermore, we describe current LPS quantification methods and the LPS-dependent inflammatory pathway and show how LPS heterogeneity can affect them. With the intent of overcoming these challenges and moving towards a universal approach for targeting LPS, we review current studies concerning LPS-specific binders. Finally, we give perspectives for LPS research and the use of LPS-binding molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, bacteria can present diverse variations of the LPS molecule, each with distinct chemical, structural, and functional heterogeneity and varying immunogenicity (Fig. 3e).134”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Lactosmart: A Novel Therapeutic Molecule for Antimicrobial Defense
Singh, J., Viswanathan, V., Ahmedi, S., Pant, P., Manzoor, N., Singh, T. P., Sharma, P., & Sharma, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.672589 · Cited by 10 · cited 3×
“Origin Binding Molecule LPS Strain (Serotype) LPS Target KD Values Citation Human MD-2 E. coli (O55:B5) Lipid A 3.2 µM [185] Human TLR4 E. coli (O55:B5) Lipid A 14.1 µM [185] Human LBP S.minnesota (Re595) Lipid A 3.5 nM [210] Human rLBP E. coli (J5) Lipid A 1.05 nM [211] Human 5I-histidine-rich polypeptide (Histatin 5…”
BackgroundInfluentialRetractedMeasurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482 · cited 1×
“Thus, it is recommended to quantify the protein content in LPS using a protein quantification method, such as the bicinchoninic acid assay [232].”
MethodDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“The most relevant innate immune receptor activated by extracellular LPS is toll–like receptor 4 (TLR4), which was identified in the late 1990s [95,96].”
BackgroundRaetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404 · cited 2×
“KDO is part of the inner core region of LPS and is present in the majority of (G-) bacteria [14].”
BackgroundHoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233 · cited 1×
“TLR4 is mainly expressed on the surface of both immune cells—such as monocytes, macrophages, neutrophils, dendritic cells, and natural killer cells [97,98]—and somatic cells—including fibroblasts and epithelial cells [97,99].”
BackgroundThe structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428 · cited 1×
“The loaded MD-2 is then recognized by TLR4 promoting the assembly of a supramolecular TLR4-CD14-MD-2 receptor complex [100,101].”
BackgroundHotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Bacterial endotoxin: molecular relationships of structure to activity and function
Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119492 · Cited by 1,607 · cited 1×
“5 kDa (R-form) to 70 kDa (S-forms with long O-antigens), being the average between 10 and 20 kDa [5,80,82].”
BackgroundLipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340 · cited 1×
“Changing the overall molecular charge by the loss or addition of phosphate groups and/or the addition of positively charged sugar units can influence the resistance against cationic antimicrobial molecules [28,29].”
Background
Research works printed but not linked: 8
- Kolmos, 2006, Panum’s Studies on “Putrid Poison” 1856, Dan. Med. Bull., 53, 450
- Williams, K.L. (2019). Discovery and Early Development of the Limulus Test, Springer International Publishing.
- Loverock, 2010, A Recombinant Factor C Procedure for the Detection of Gram-Negative Bacterial Endotoxin, United States Pharmacop. Conv.-Pharmacop. Forum, 36, 321
- Dawson, 1993, Endotoxin Standards and CSE Potency, LAL Updat., 11, 1
- Tsuchiya, 2014, Possible Mechanism of Low Endotoxin Recovery, Am. Pharm. Rev., 17, 1
- Meadows, 2018, Aseptic Sampling Best Practices Endotoxin Binding Affinity, Sartorius, SP-4006-e, 1
- Novitsky, 1988, The Problems with Plastics, Lal Update, 6, 1
- (2023, February 12). PubMed Keyword “Endotoxin” 5203 Events, Keyword “Lipopolysaccharide” 7853 Events, Available online: https://pubmed.ncbi.nlm.nih.gov/.
Cited by
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Cicchinelli, S., Pignataro, G., Gemma, S., Piccioni, A., Picozzi, D., Ojetti, V., Franceschi, F., & Candelli, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020962 · Cited by 155
“Recently, it has been highlighted that LPS may enter the cell via a clathrin-mediated endocytosis of outer membrane vesicles (OMVs), or through the preliminary extracellular binding to the HMGB1 protein, and subsequent conjunction with RAGE [45].”
BackgroundInfluentialLipopolysaccharide delivery systems in innate immunity
Liu, J., Kang, R., & Tang, D. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.02.003 · Cited by 113
Peregrino, E. S., Castañeda‐Casimiro, J., Vázquez-Flores, L., Estrada-Parra, S. A., Baeza, C. W., Serafín‐López, J., & Wong‐Baeza, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116210 · Cited by 70
Boronic acid-assisted detection of bacterial pathogens: Applications and perspectives
Gao, S., Zhang, Y., Zhou, R., Shen, T., Zhang, D., Guo, Z., & Zou, X. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216082 · Cited by 57
Michelini, S., Mawas, S., Kurešepi, E., Barbero, F., Šimunović, K., Miremont, D., Devineau, S., Schicht, M., Ganin, V. S., Haugen, Ø. P., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03419-6 · Cited by 40
“Thus, in this context, the use of this assay is particularly relevant as it more closely reflects the natural response of cells to endotoxins when compared, for example, to a standard limulus amoebocyte lysate assay (LAL) [37, 38].”
Self-citationDardelle, F., Phelip, C., Darabi, M., Kondakova, T., Warnet, X. L., Combret, E., Juranville, E., Novikov, A., Kerzerho, J., & Caroff, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073927 · Cited by 39
Aggregatibacter actinomycetemcomitans: From the Oral Cavity to the Heart Valves
Talapko, J., Juzbašić, M., Meštrović, T., Matijević, T., Mesarić, D., Katalinić, D., Erić, S., Milostić-Srb, A., Flam, J., & Škrlec, I. (2024) · Microorganisms · doi:10.3390/microorganisms12071451 · Cited by 42
Bonhomme, D., Cavaillon, J., & Werts, C. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105506 · Cited by 32
Hospital Acquired Sepsis, Disease Prevalence, and Recent Advances in Sepsis Mitigation
Garvey, M. (2024) · Pathogens · doi:10.3390/pathogens13060461 · Cited by 33
“The LPA toxin released during BSIs with these pathogens varies amongst each GNB species, with its structure, length, lipid chain and sugar unit content determining its endotoxic pyrogenic effect [53].”
BackgroundAlvandi, H., Asadi, F., Rezayan, A. H., Hajghassem, H., & Rahimi, F. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.343816 · Cited by 29
Tume, R., Sherbiny, S. E., Bono, R., Gautier, T., de Barros, J.-P. P., & Meroño, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1588129 · Cited by 29
Immunotherapy in the context of sepsis-induced immunological dysregulation
Wu, Y., Wang, L., Li, Y., Cao, Y., Wang, M., Deng, Z., & Kang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391395 · Cited by 35
Gut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
“For example, supplementation with A. muciniphila has been shown to lower circulating LPS, LBP, and in fl ammatory cytokines in mouse models.”
InfluentialDental Stem Cells and Lipopolysaccharides: A Concise Review
Rodas-Junco, B. A., Hernández-Solís, S. E., Serralta-Interian, A. A., & Rueda-Gordillo, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084338 · Cited by 20
Rusciano, G., Capaccio, A., Sasso, A., Capo, A., Almuzara, C. M., Staiano, M., D’Auria, S., & Varriale, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512099 · Cited by 21
“In fact, upon interaction with human cell membrane receptors (toll-like receptors, such as TRL4), LPS activates the production of inflammatory cytokines and chemokines, which contribute to the inflammatory process with the severe effects of septic shock syndrome [1,2].”
BackgroundMethodEndotoxin’s Impact on Organism: From Immune Activation to Tolerance and Beyond
Roszak, K., Roy, K., Sobocińska, J., Spisz, P., Jędrzejewski, T., & Wrotek, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186478 · Cited by 17
“LPS is a molecule that readily undergoes modifications and varies between different bacterial strains of origin, substantially reducing its detectability [181].”
The interaction between oral microbiota and gut microbiota in atherosclerosis
Li, X., Li, Q., Wang, L., Ding, H., Wang, Y., Liu, Y., & Gong, T. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1406220 · Cited by 15
Lira, A. L., Taskin, B., Puy, C., Keshari, R. S., Silasi‐Mansat, R., Pang, J., Aslan, J. E., Shatzel, J. J., Lorentz, C. U., Tucker, E. I., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108110 · Cited by 12
Eid, F., Boushehri, M., Boucher, C., Rajkanth, N., Sa, A. F., Alhoutan, T., Vavetsi, K., Dibart, S., & Ma, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202403117rr · Cited by 10
Schromm, A. B., Correa, W., Gisch, N., Steiniger, F., Richter, W., de Tejada, G. M., Brandenburg, K., & von Wintzingerode, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116286 · Cited by 10
Bermúdez-Puga, S., Mendes, B. D. S., Ramos-Galarza, J. P., de Azevedo, P. O. D. S., Converti, A., Molinari, F., Moore, S. J., Almeida, J. R., & Oliveira, R. P. D. S. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108605 · Cited by 9
New Promising Targets for Imaging in Cardiovascular Diseases
Ståhle, M. R., Popescu, C. E., Rischpler, C., Zhang, H., Massalha, S., Lopes, L. R., Rominger, A., & Caobelli, F. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.05.006 · Cited by 9
Synthesis and biological evaluation of lipid A derived from commensal Bacteroides
Verpalen, E. C. J. M., Ehlers, A. M., van Wingaarden, A. C. A., Brouwer, A. J., & Boons, G. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob01340a · Cited by 9
Jandosov, J., Berillo, D. A., Misra, A., Alavijeh, M. S., Chenchik, D., Baimenov, A., Bernardo, M., Азат, С., Mansurov, Z. A., Silvestre‐Albero, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030952 · Cited by 10
“Endotoxin concentrations measured in 69 point-of-use water treatment systems and tap waters in South Korea varied within the ranges of 0.8–79.1 EU × mL − 1 and 0.1–3.4 EU × mL − 1 , respectively [60].”
InfluentialMelo, C. C. D., Fux, A. C., Himly, M., Bastús, N. G., Schlahsa, L., Siewert, C., Puntes, V., Duschl, A., Gessner, I., & Fauerbach, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813971 · Cited by 9
“The intensity of the immune re‐ sponse against LPS can be different depending on the LPS source and concentration, but, in general, LPS has been described to trigger the release of inflammatory cytokines upon activation of the TLR4 pathway, with symptoms ranging from fever up to life‐threatening conditions, such as se…”
BackgroundSelf-citationBacterial infection and activation of the contact pathway of coagulation
Lira, A. L., Puy, C., Shatzel, J. J., Lupu, F., & McCarty, O. J. T. (2025) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2025.100091 · Cited by 8
“60,61 Lipid A anchors LPSs, whereas the core maintains membrane integrity.”
Oliynyk, R. T., Mahas, A., Karpinski, E., & Church, G. M. (2025) · Communications Biology · doi:10.1038/s42003-025-09157-7 · Cited by 9
“Wehypothesizedthatendotoxinreductionoccursduringthedigestion stage, where T5 exonuclease and the Ssp I restriction enzyme bind endo-toxins, forming protein-endotoxin complexes 43,44 that are subsequently removed during washing.”
The role of gut microbiota associated metabolites in digestive disorders
Li, N., Zhao, C., Zhang, P., Wu, S., Dou, X., Xu, S., Zhang, X., Peng, C., Xie, Y., Huang, S., et al. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.04.003 · Cited by 9
Detection of Salmonella by competitive ELISA of lipopolysaccharide secreted into the culture medium
Kiseleva, E. P., Mikhailopulo, K. I., & Sviridov, O. V. (2024) · Analytical Biochemistry · doi:10.1016/j.ab.2024.115695 · Cited by 8
Dimeji, I. Y., & Ayodeji, A. S. (2025) · ASPET Discovery · doi:10.1016/j.aspetd.2025.100010 · Cited by 8
Fux, A. C., Melo, C. C. D., Schlahsa, L., Burzan, N. B., Felsberger, A., Gessner, I., Fauerbach, J. A., Horejs‐Hoeck, J., Droste, M., & Siewert, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042297 · Cited by 8
“Even low levels of LPS can trigger strong immune reactions in the human circulatory system, resulting in proinflammatory cytokine secretion (e.g., IL-6, IL-1 β , and TNF α ) [2,3].”
BackgroundSelf-citationSepsis modelling: current approaches and organ-on-chip perspectives
Silva, M. J., Fehrenbach, G. W., Pogue, R. E., Murray, P., Rezoagli, E., Laffey, J. G., & Murphy, E. J. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106120 · Cited by 6
Mikołajczyk, M., Złotkowska, D., & Mikołajczyk, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211868 · Cited by 8
Gupta, A., & Guptasarma, P. (2024) · Journal of Bacteriology · doi:10.1128/jb.00309-24 · Cited by 6
“Multiple hypoth eses abound regarding how biofilms form through the phase separation of bacterial populations from their immediate environments (15).”
Review of experimental equine synovitis models for inducing lameness
Dockery, A., Beasley, B., & Moorman, V. J. (2025) · Equine Veterinary Education · doi:10.1111/eve.14207 · Cited by 3
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection
da Silva, A. L. L., Drew, K. C., Puy, C., Shatzel, J. J., & McCarty, O. J. T. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2716-6782 · Cited by 3
Ghods, S., Muszyński, A., Yang, H., Seelan, R. S., Mohammadi, A., Hilson, J. S., Keiser, G., Nichols, F. C., Azadi, P., Ernst, R. K., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1418651 · Cited by 3
Factors Promoting Lipopolysaccharide Uptake by Synthetic Lipid Droplets
Arnob, A., Gairola, A., Clayton, H. W., Jayaraman, A., & Wu, H. (2025) · ACS Omega · doi:10.1021/acsomega.4c09599 · Cited by 3
Mohamed, I., Burckhardt, K., & Lohse, S. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf086 · Cited by 3
Srinontong, P., Aengwanich, W., Somphon, S., Khonwai, S., Nitsinsaku, T., Wu, Z., Chalalai, T., Saraphol, B., & Srisanyong, W. (2024) · Veterinary World · doi:10.14202/vetworld.2024.804-810 · Cited by 3
Zhang, Q., Wang, Y., Ma, D., Pan, X., Sheng, E., Shen, J., Liang, D., Wang, C., Qian, C., Qian, W., et al. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06567-y · Cited by 3
Śmiałek, J., Bzowska, M., Frączek, A., Wojda, I., Mężyk-Kopeć, R., Bonarek, P., Blat, A., Rak, J., & Mak, P. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00066 · Cited by 2
Gupta, A. M., Habib, H., Hassan, B. A., Butelman, J. W., Gorman, A., Arevalo, P., & Taylor, E. A. (2026) · Protein Science · doi:10.1002/pro.70458 · Cited by 2
“The biosynthesis of LPS exhibits considerable diversity among Proteobacteria, influenced by environmental pressures that drive subtle yet significant modifications in their structural and functional properties (Fux et al., 2023).”
Soil Sustainability Around Municipal Waste Landfill Area Is Affected by Microbial Contamination
Kozdrój, J., Frączek, K., Górny, R. L., & Ropek, D. R. (2026) · Sustainability · doi:10.3390/su18062846 · Cited by 2
Molecular basis for inhibition of α-thrombin activity by bacterial lipopolysaccharides
Lira, A. L., Drew, K. C., Dantas, R. L. M., Pang, J., & McCarty, O. J. T. (2026) · Scientific Reports · doi:10.1038/s41598-026-46276-5 · Cited by 2
Wei, F., Nakahara, Y., Isobe, J., Igarashi, Y., Saito, H., Murakami, S., Kondo, T., Himuro, H., Kouro, T., Matsui, T., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1832317 · Cited by 3
“The O-antigen is the most variable region of lipopolysaccharide and serves as a major B-cell antigen capable of eliciting antigen-speci fi c immune responses (38, 39); microbial O-antigens have also been reported to promote natural killer cell activation (40).”
Wang, W., Zhang, Y., Zhang, H., Jayan, H., Vukić, M., Vujadinović, D., Waterhouse, G. I. N., Zou, X., & Guo, Z. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.119057 · Cited by 2
LPS in gram-negative bacterial growth and physiology: outside but fully integrated
Valdez, R. A., & Levin, P. A. (2026) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00394-25 · Cited by 2
Babaev, M. A., Тухтаманова, А. С., & Masneva, A. I. (2024) · Annals of critical care · doi:10.21320/1818-474x-2024-1-135-147 · Cited by 2
Bácsi, A., Ágics, B., Pázmándi, K., Kocsis, B., Sándor, V., Bertók, L., Bruckner, G. G., & Sipka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031581 · Cited by 2
Lily extract ameliorate mouse pneumonia by modulating ciliary function
Sun, Z., Xu, D., Wang, X., Zhou, J., Xiao, N., Jia, R., Huang, D., Tang, D., Xia, T., & Xiao, F. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106603 · Cited by 2
A new test system for Salmonella detection in food products by competitive immonoassay
Kiseleva, E. P., Mikhailopulo, K. I., & Sviridov, O. V. (2025) · Proceedings of the National Academy of Sciences of Belarus Biological Series · doi:10.29235/1029-8940-2025-70-1-55-68 · Cited by 2
Uchida, S., Yokobori, T., Yanagisawa, K., Erkhem‐Ochir, B., Dorjkhorloo, G., Okami, H., Katayama, C., Shibasaki, Y., Nakazawa, N., Komine, C., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17773-0 · Cited by 3
“42 However, larger LPS molecules may bind to proteins with nuclear localization signals, such as HMGB1, and be actively transported through nuclear pore complexes.”
Zheng, Z., Li, J., Pan, G., Wang, J., Wang, Y., Peng, K., Zhang, X., Huang, Z., & Weng, S. (2024) · Chemosensors · doi:10.3390/chemosensors12100201 · Cited by 1
Progress in Characterization of Lipopolysaccharides and Lipid A by Mass Spectrometry
Helms, A., & Brodbelt, J. S. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21934 · Cited by 1
“As outlined above, the heterogeneity of LPS is vast, and this contributes to the difficulty in characterizing LPS with typical bioas-says and often requires extensive sample preparation and multiple analytical methods (Fux et al. 2023).”
Improved in silico and in vitro methods for Escherichia coli LPS outer core typing
Trofimova, E., Westerman, R. P., & Jaschke, P. R. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001506 · Cited by 1
“The outer core LPS is highly variable across different Gram-negative bacterial strains [8].”
Martins, A. M. D. O., Soares, M. F. D. S., de Oliveira, L. N., Barbosa, N. M. M. V., Matos, A. L. L. D. S., Gonçalves, M. C. F., Golzio, A. M. F. D. O., Felipe, C. F. B., Scotti, M. T., da Silva, P. R., et al. (2026) · Journal of Xenobiotics · doi:10.3390/jox16040129 · Cited by 1
“In addition, structural variations in LPS derived from different bacterial species may result in distinct inflammatory activation profiles, affecting the reproducibility and sensitivity of bioassays [185,186].”
Dzieciątkowska, M., Koj, S., Ucieklak, K., Łukasiewicz, J., Ługowski, C., & Niedziela, T. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125767 · Cited by 1
Bajić, D., Vučković, J., Pupovac, N., Slavić, D., Stojsic, M., Hodoba, N., Todorović, N., Plazačić, M., & Milosevic, N. P. (2026) · Medical Sciences · doi:10.3390/medsci14050536 · Cited by 1
Uliginosin B, a Natural Phloroglucinol, Increases Hippocampal GSH, MCP-1 and IL-10 Levels in Mice
Marangon, C. G., Rojas, C., Michelsen, M. Z., Sakamoto, S., Jacques, C. E. D., von Poser, G. L., Vargas, C. R., & Rates, S. M. K. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00459-7 · Cited by 1
“In addition, is noteworthy to mention that LPS heterogeneity may be source of variability in bioassays, including LPS-dependent inflammatory pathway (Fux et al. 2023).”
BackgroundInactivating Host Bacteria for Characterization and Use of Phages
Chambers, J. P., Wright, E. T., Hunter, B., & Serwer, P. (2023) · Biophysica · doi:10.3390/biophysica3040038 · Cited by 1
Eworo, R. E., Fabian, U. A., Ntamu, N. A., Thomas, C. C., Egom, U. O., Nsonwu, M. C., Basake, R. U., ESSIEN, A. U., Ekam-Ukere, I. M., & Nsonwu-Anyanwu, A. C. (2023) · Global Journal of Pure and Applied Sciences · doi:10.4314/gjpas.v29i2.16 · Cited by 1
Matea, T., Badnjević, M., Žigante, M., Dong, A., Zarić, S., & Špalj, S. (2025) · Clinical Oral Investigations · doi:10.1007/s00784-025-06406-1 · Cited by 1
“Lipopolysaccharides can safely be stored at − 20 °C for several months; however, freeze/thaw cycles must be avoided to ensure that intact molecules are present [29].”
Laskowski, D., & Strzelecki, J. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04529-3
“Much of this research has focused on uncovering the drivers of diversity, particularly at the molecular level (Avery 2006; Carlquist et al. 2012; Martins and Locke 2015; Davis and Isberg 2016; Heyse et al. 2019; Fux et al. 2023).”
InfluentialTamura, T., Ohsugi, Y., Katagiri, S., Kusano, A., Handa, T., Lin, P., Liu, A., Toyoshima, K., Takagi, S., Shiwaku, H., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf212
Sepsis and endotoxin: A brief history
Foster, D., & Kellum, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00003-2
Hurst, S. M., Laven, R. A., & Pernthaner, A. (2026) · Animals · doi:10.3390/ani16020310
“Gram-negative bacteria generate specific LPS compounds that can be endotoxic and drives the acute inflammatory response observed in Gram-negative infections [7,25].”
Salom, M. E. (2026) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Do, Y.-J., Kim, S.-Y., Cho, Y. E., Cho, S.-Y., Lee, S. J., Lee, Y.-W., Lee, S.-W., Lee, N.-H., Lee, S., Bae, H. J., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121550
Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium
Willocx, M., Pirnay, J., Merabishvili, M., Laurent, F., Clouet, S., Lavigne, R., Ceyssens, P., & Vanhee, C. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115068
Boeck, M. D., Choque, F. S., Vella, M. A., Roldán‐Olarte, M., & Valdecantos, P. A. (2026) · Theriogenology · doi:10.1016/j.theriogenology.2026.117958
Ma, R., Huang, J., Chen, Y., Wang, H., Zou, H., Zhao, W., & Deng, Z. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70131
Başkut, A. Ü., Yazıcılar, B., Atıcı, Ö., Halis, B., & Geyik, M. Ş. (2026) · Biology Bulletin · doi:10.1134/s1062359025609620
“These findings indicate that LPS molecules from Gram-negative bacteria share common structural features, consistent with previous reports on Salmonella lipid A and Re-LPS forms (Kim et al., 2005; Fux et al., 2023).”
Harsini, H., Hendrawati, H., & Annisa, M. (2026) · Cumhuriyet Dental Journal · doi:10.7126/cumudj.1777957
Rani, R., Adhikari, A., & Kumar, S. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/9526059
Metabolic endotoxemia in metabolic and neurodegenerative diseases
Li, C., Jiang, W., & Lu, M. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026130
Wang, M., Wen, X., Li, X., Li, H., Cheng, J., & liu, M. (2026) · Virulence · doi:10.1080/21505594.2026.2707822
“Importantly, the inflammatory activity of LPS may vary depending on the strain or serotype of E. coli [111,112].”
Zhang, X., Xian, Y., & He, G. (2026) · Sensors · doi:10.3390/s26154821
Zhang, D., Li, R., Wang, R., Tang, Y., Luosang, L., Zhao, X., Li, Q., Zhao, X., & Liang, Y. (2026) · Biology · doi:10.3390/biology15151264
“Although the immobilized LPS model can reflect direct binding behavior, it cannot fully recapitulate the native arrangement of LPS and the membrane microenvironment in the bacterial outer membrane [2,5].”
Tatsumi, A., Koyama, N., & Yamashita, M. (2026) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.6c00157
Suarez‐Arnedo, A., Thomas, J. L., Liu, Y., Alvarado, P. C., Kim, A., Espinoza, M. A. C., Harvey, L., Poysungnoen, K., Lin, F., Ye, Z., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71572
“As expected, LPS exhibited the strongest interaction with MD-2, achieving sub-micromolar affinity ( K D = 9.10 × 10 − 7 M), in agreement with previous reports [26, 27].”
InfluentialQu, D., Wang, Z., 冯赛赛, 张亮亮, Hou, Q., Wang, Y., Zhao, H., Guo, Z., & Xu, J. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.106124
Zhang, L., Tong, F., Liao, J., Xiao, N., Lu, F., Li, H., Gao, F., Ma, L., Chen, M., & Ding, C. (2026) · European Polymer Journal · doi:10.1016/j.eurpolymj.2026.115184
Metadata
- Authors
- Fux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M.
- Affiliations
- Miltenyi Biotec (Germany) (DE)
- Division of Allergy & Immunology, Department of Biosciences & Medical Biology, Paris Lodron University of Salzburg (PLUS), Hellbrunnerstraße 34, 5020 Salzburg, Austria
- University of Ljubljana (SI)
- Colorado State University (US)
- Heinrich Heine University Düsseldorf (DE)
- Stazione Zoologica Anton Dohrn (IT)
- University of Salzburg (AT)
- Corresponding author
- Himly, Martin
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-05-07
- Volume
- 24
- Issue
- 9
- Pages
- 8395
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10179214
- OpenAlex
- W4375862682
- Cited by
- 83
- References
- 225
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 6
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (submittedVersion, cc-by)
- Funders
- European Union’s Horizon 2020 research and innovation programme (H2020-MSCA-ITN-2018-812661, 890610)
- Austrian Research Promotion Agency (FFG) (H2020-MSCA-ITN-2018-812661, 890610)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- lipopolysaccharide, endotoxin, LPS-binding protein, Gram-negative bacteria, pathogen-associated molecular patterns, septic shock
- MeSH terms
- Biological Assay, Endotoxins, Humans, Lipopolysaccharides, Shock, Septic, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.